Opko Health Inc. (OPK)

Price$1.44

Value ScoreB

Growth ScoreC

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-2.04%

Price vs S&P 500 (4W)26.33%

VGM Score58.39

Market Capitalization$1.09B

All Metrics

Book Value / Share (Quarterly)$1.60

P/TBV (Annual)1.74x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)3.64%

Cash Flow / Share (Quarterly)$-0.23

Price vs S&P 500 (YTD)6.13%

Gross Margin (TTM)38.00%

Net Profit Margin (TTM)-36.49%

EPS (TTM)$-0.27

10-Day Avg Trading Volume3.42M

EPS Excl Extra (TTM)$-0.27

Revenue Growth (5Y)0.78%

EPS (Annual)$-0.30

ROI (Annual)-13.98%

Gross Margin (Annual)28.70%

Net Profit Margin (5Y Avg)-12.72%

Cash / Share (Quarterly)$0.45

Revenue Growth QoQ (YoY)-17.33%

ROA (Last FY)-11.70%

Revenue Growth TTM (YoY)-28.95%

EBITD / Share (TTM)$-0.15

ROE (5Y Avg)-9.40%

Operating Margin (TTM)-33.22%

Cash Flow / Share (Annual)$-0.25

P/B Ratio0.90x

P/B Ratio (Quarterly)0.72x

Net Income / Employee (Annual)$-99,300

EV / Revenue (TTM)2.47x

Net Interest Coverage (TTM)-14.69x

ROA (TTM)-10.93%

EPS Growth QoQ (YoY)-22.63%

EV / EBITDA (TTM)7.82x

EPS Incl Extra (Annual)$-0.30

Current Ratio (Annual)3.96x

Quick Ratio (Quarterly)3.10x

3-Month Avg Trading Volume2.61M

52-Week Price Return5.11%

Revenue / Employee (TTM)$255,400

Tangible BV / Share (Quarterly)$0.68

P/S Ratio (Annual)1.79x

Asset Turnover (Annual)0.31x

52-Week High$1.60

Operating Margin (5Y Avg)-9.74%

EPS Excl Extra (Annual)$-0.30

CapEx CAGR (5Y)-11.98%

Tangible BV CAGR (5Y)-1.70%

26-Week Price Return5.88%

Quick Ratio (Annual)3.42x

13-Week Price Return23.08%

Total Debt / Equity (Annual)0.28x

Current Ratio (Quarterly)3.61x

Enterprise Value$1.44B

Revenue / Share Growth (5Y)-4.17%

Asset Turnover (TTM)0.30x

Book Value / Share Growth (5Y)-9.31%

Revenue / Employee (Annual)$266,800

Inventory Turnover (Annual)8.92x

Pretax Margin (Annual)-39.70%

Cash / Share (Annual)$0.48

3-Month Return Std Dev43.53%

Gross Margin (5Y Avg)34.81%

Net Income / Employee (TTM)$-93,200

EBITDA Interim CAGR (5Y)11.35%

ROE (Last FY)-17.82%

Net Interest Coverage (Annual)-25.97x

EPS Basic Excl Extra (Annual)$-0.30

P/FCF (TTM)33.18x

Receivables Turnover (TTM)7.21x

Total Debt / Equity (Quarterly)0.29x

EPS Incl Extra (TTM)$-0.27

Receivables Turnover (Annual)5.19x

ROI (TTM)-13.10%

P/S Ratio (TTM)1.87x

Pretax Margin (5Y Avg)-13.74%

Revenue / Share (Annual)$0.81

Tangible BV / Share (Annual)$0.73

Free OCF CAGR (5Y)10.98%

Price vs S&P 500 (52W)-19.26%

EPS Growth TTM (YoY)39.22%

Year-to-Date Return14.29%

5-Day Price Return2.86%

EPS Normalized (Annual)$-0.30

ROA (5Y Avg)-6.47%

Net Profit Margin (Annual)-37.23%

Month-to-Date Return-1.37%

Cash Flow / Share (TTM)$-0.14

EBITD / Share (Annual)$-0.17

Operating Margin (Annual)-34.43%

LT Debt / Equity (Annual)14.51x

ROI (5Y Avg)-7.40%

LT Debt / Equity (Quarterly)15.84x

EPS Basic Excl Extra (TTM)$-0.27

P/TBV (Quarterly)1.68x

P/B Ratio (Annual)0.76x

Inventory Turnover (TTM)5.80x

Pretax Margin (TTM)-39.59%

Book Value / Share (Annual)$1.67

Price vs S&P 500 (13W)14.82%

Beta1.49x

P/FCF (Annual)157.21x

Revenue / Share (TTM)$0.77

ROE (TTM)-16.71%

52-Week Low$0.98

vGradeB

gGradeC

mGradeB

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.07est. -0.07

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.00

3.82

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
OPKOpko Health Inc.	B	C	B	$1.44
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

OPKO Health is a diversified biotechnology company with pharmaceutical and diagnostics segments operating globally. Its diagnostics division, which generates the majority of revenue, operates clinical and genomics laboratories through BioReference and point-of-care services. The pharmaceutical segment focuses on research, development, and commercial operations across multiple countries.